At AHA 2021, some major clinical trials broke new ground with familiar agents while others validated management approaches previously informed largely by clinical experience. Here’s my take.
Here are my thoughts on the exciting studies of novel therapies in heart failure, including a myosin inhibitor, statin use, and electrical cardioversion for atrial fibrillation.
At AHA 2021, new data on the use of telehealth platforms demonstrated that video visits are a feasible approach to managing patients with heart failure.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.